Urgo Healthcare Belgium Completes Acquisition of Vista-Life Pharma

Deal News | Feb 05, 2025 | Finance Community IT - 1 Corporate M&A

Urgo Healthcare Belgium Completes Acquisition of Vista-Life Pharma

Urgo Healthcare Belgium has successfully acquired Vista-Life Pharma, a Belgian company specializing in the commercialization of dietary supplements. Alisea Corporate Finance provided financial advisory services for Urgo during the transaction. The integration of these two entities will enhance the variety of solutions available to patients and strengthen Urgo's market position. As part of the acquisition, Veronique Reynders, co-founder of Vista-Life Pharma, will join Urgo Healthcare Belgium as the head of the OTX commercial activity, alongside Gauthier Lauwers.

Sectors

  • Healthcare
  • Corporate Finance

Geography

  • Belgium – Both Urgo Healthcare Belgium and Vista-Life Pharma are Belgian companies, and the acquisition impacts the Belgian healthcare market.

Industry

  • Healthcare – The article involves healthcare companies, with Urgo Healthcare Belgium and Vista-Life Pharma operating in the health supplements sector.
  • Corporate Finance – Alisea Corporate Finance facilitated the transaction as a financial advisor, indicating the corporate finance industry's involvement.

Financials

    Participants

    NameRoleTypeDescription
    Urgo Healthcare BelgiumBidding CompanyCompanyA healthcare company that acquired Vista-Life Pharma.
    Vista-Life PharmaTarget CompanyCompanyA Belgian company specializing in dietary supplements, acquired by Urgo Healthcare Belgium.
    Alisea Corporate FinanceFinancial AdvisorCompanyProvided financial advisory services for Urgo Healthcare Belgium during the acquisition of Vista-Life Pharma.
    Veronique ReyndersHead of OTX Commercial ActivityPersonCo-founder of Vista-Life Pharma, joining Urgo Healthcare Belgium post-acquisition.
    Gauthier LauwersCommercial Activity OTXPersonAlong with Veronique Reynders, involved in the OTX commercial activity at Urgo Healthcare Belgium.